pubmed.ncbi.nlm.nih.gov

The functional consequences of mis-sense mutations affecting an intra-molecular salt bridge in arylsulphatase A - PubMed

  • ️Tue Jan 01 2002

Case Reports

. 2002 Oct 15;367(Pt 2):499-504.

doi: 10.1042/BJ20020286.

Affiliations

Case Reports

The functional consequences of mis-sense mutations affecting an intra-molecular salt bridge in arylsulphatase A

Frank Schestag et al. Biochem J. 2002.

Abstract

Metachromatic leukodystrophy is a lysosomal storage disorder caused by the deficiency of arylsulphatase A. We describe the functional consequences of three mis-sense mutations in the arylsulphatase A gene (Asp-335-Val, Arg-370-Trp and Arg-370-Gln), affecting an apparent intramolecular Asp-335 to Arg-370 salt bridge, and interpret the effects and clinical consequences on the basis of the three-dimensional structure of arylsulphatase A. Asp-335-Val and Arg-370-Trp substitutions each cause a complete loss of enzyme activity and are associated with the most severe form of the human disease, whereas the Arg-370-Gln-substituted enzyme retains some residual activity, being found in a patient suffering from the milder juvenile form of the disease. Detailed analysis reveals that formation of the apparent salt bridge depends critically on the presence of aspartic acid and arginine residues at positions 335 and 370, respectively. Substitution by various other amino acids, including glutamic acid and lysine, affects enzyme function severely. Biosynthesis and immunoprecipitation studies indicate that the Asp-335-Val substitution affects folding of arylsulphatase A more severely than either the Arg-370-Trp or Arg-370-Gln substitutions. In vitro mutagenesis data show that clinical severity correlates with the space occupied by residue 370. The combination with structural data suggests that the bulky tryptophan residue broadens the cleft held together by the apparent salt bridge, whereas the smaller glutamine residue still allows the cleft to close, yielding a less severely affected enzyme. The position of residue 370 in the three-dimensional structure of the enzyme provides a plausible explanation for the differing severities in loss of enzyme function caused by the mutations and thus the clinical phenotype.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Biol Chem. 1999 Dec 3;274(49):34535-8 - PubMed
    1. J Biol Chem. 1999 Feb 26;274(9):5429-35 - PubMed
    1. Exp Cell Res. 1988 Jun;176(2):258-67 - PubMed
    1. Gene. 1988 Sep 7;68(2):213-9 - PubMed
    1. Annu Rev Cell Biol. 1989;5:483-525 - PubMed

Publication types

MeSH terms

Substances